FDA.reportPublic FDA data

Prostate-specific membrane antigen (PSMA) IVD, control

Definition
A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of prostate-specific membrane antigen (PSMA), also known as glutamate carboxypeptidase 2, in a clinical specimen.
GUDID devices
2
Last updated
2025-03-26 08:21:28

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
B502BSB9358CS0PSMA Control SlidesBIO SB, INC.BSB-9358-CS2025-03-18
B502BSB63510PSMA Control SlidesBIO SB, INC.Control Slides, 5 2020-08-31